Access to anti-retroviral drugs, male in Montenegro
Montenegro: Access to anti-retroviral drugs, male was 61.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Montenegro, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, male in Montenegro stood at 61.0%. That is the highest value across all 25 years on record.
That represents a change of up 5.2% on the previous year and up 84.8% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Montenegro peaked at 61.0% in 2024 and was at its lowest, 5.0%, in 2000.
That places Montenegro 97th out of 141 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Montenegro, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 5.0% | — |
| 2001 | 9.0% | +80.0% |
| 2002 | 10.0% | +11.1% |
| 2003 | 10.0% | +0.0% |
| 2004 | 11.0% | +10.0% |
| 2005 | 17.0% | +54.5% |
| 2006 | 19.0% | +11.8% |
| 2007 | 20.0% | +5.3% |
| 2008 | 21.0% | +5.0% |
| 2009 | 23.0% | +9.5% |
| 2010 | 27.0% | +17.4% |
| 2011 | 27.0% | +0.0% |
| 2012 | 28.0% | +3.7% |
| 2013 | 31.0% | +10.7% |
| 2014 | 33.0% | +6.5% |
| 2015 | 34.0% | +3.0% |
| 2016 | 40.0% | +17.6% |
| 2017 | 46.0% | +15.0% |
| 2018 | 50.0% | +8.7% |
| 2019 | 52.0% | +4.0% |
| 2020 | 54.0% | +3.8% |
| 2021 | 54.0% | +0.0% |
| 2022 | 55.0% | +1.9% |
| 2023 | 58.0% | +5.5% |
| 2024 | 61.0% | +5.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 14.5% | 5.0% | 23.0% | 10 |
| 2010s | 36.8% | 27.0% | 52.0% | 10 |
| 2020s | 56.4% | 54.0% | 61.0% | 5 |
Countries ranked near Montenegro
- 94 Bhutan 62.0% compare
- 94 Guinea-Bissau 62.0% compare
- 94 Timor-Leste 62.0% compare
- 97 Central African Republic 61.0% compare
- 97 Costa Rica 61.0% compare
- 97 Lao People's Democratic Republic 61.0% compare
- 97 Paraguay 61.0% compare
More gender data for Montenegro
- Child population (UN estimates and projections) 102.79 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -1.87 % change on previous year (2030)
- Population 509.77 (2030)
- Working-age population (UN estimates and projections) 509.77 (2030)
- Population (UN estimates and projections), annual growth rate -0.2985 % change on previous year (2030)
- Age population, age 00, female, interpolated 3,317 (2025)
- Age population, age 00, male, interpolated 3,550 (2025)
- Age population, age 01, female, interpolated 3,345 (2025)
- Age population, age 01, male, interpolated 3,587 (2025)
- Age population, age 02, female, interpolated 3,447 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Montenegro?
- Access to anti-retroviral drugs, male in Montenegro was 61.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Montenegro?
- The highest recorded value was 61.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in Montenegro?
- The lowest recorded value was 5.0% in 2000.
- How does Montenegro rank for access to anti-retroviral drugs, male?
- Montenegro ranks 97th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Montenegro?
- Over the last ten years it is up 84.8%. The long-run trend across the full record is volatile.
- Where does this Montenegro data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.